doi: 10.3389/fphar.2022.856111 Received 16 January 2022 Accepted 15 February 2022 Published 08 March 2022 Volume 13 - 2022 Edited by Giuseppe Paolisso, University of Campania Luigi Vanvitelli, Italy Reviewed by Stefano Ciardullo, University of Milano Bicocca, Italy Maria Rosaria Rizzo, University of Campania Luigi Vanvitelli, Italy Updates Copyright 2022 Pahud de Mortanges, Sinaci, Salvador, Bally, Muka, Wilhelm and Bano
None of this means the drug is unsafe at scale, the STEP and SUSTAIN trials placed the discontinuation-for-AE rate at 4.3 percent, but the individual stories above are the people who landed inside that 4.3 percent
It causes people to maintain their weight if they lose it by another method for the most part, he said
It reduces appetite, slows gastric emptying, improves insulin sensitivity, and produces meaningful reductions in body weight over time